We searched Medline (from 1946 to May 15, 2012), Scopus (from 1950 to May 15, 2012), and Embase (from 1947 to May 15, 2012) databases, using detailed search strategies (appendix). We developed search methods to capture clinical and experimental evidence of cardiac complications in patients with pneumonia, and the effects of pneumonia on the human cardiovascular system, the consequences of commonly used cardiovascular drugs on the outcomes of patients with pneumonia, and the effects of available
ReviewAcute pneumonia and the cardiovascular system
Introduction
Pneumonia and cardiac disease are leading causes of morbidity and mortality worldwide.1, 2, 3, 4, 5 Community-acquired pneumonia affects more than 5 million adults, and causes 1·1 million hospital admissions and more than 60 000 deaths every year in the USA.1, 2 Cardiac disease affects more than 30 million US adults and leads to 5 million hospital admissions and more than 300 000 deaths every year.3, 6 Disease burdens in Europe are similar.4, 5, 7 Pneumonia and cardiac disease often coexist in the same patients.8 For example, more than half of elderly patients admitted to hospital with pneumonia also have a chronic cardiac disorder—an association that will become more prevalent as the population continues to age.8
Investigators have reported a high incidence of cardiac complications during the course of community-acquired pneumonia, and have shown that these events are independently associated with increased short-term mortality.9 In view of this association, full appreciation of the magnitude of this problem and an understanding of the cardiovascular consequences of this infection are important. In this Review, we summarise the present knowledge about the burden of cardiac complications in adult patients with pneumonia, the cardiovascular response to acute pneumonia, and the potential effects of commonly used cardiovascular and anti-infective drugs on these associations. We also discuss potential areas for future research.
Section snippets
Burden of cardiac complications in patients with pneumonia
For several decades, investigators have noted that acute respiratory infections, including pneumonia, often precede the development of acute cardiac events, and a causal relation has been proposed.10, 11 For acute coronary syndromes specifically, this association satisfies most of Bradford Hill's criteria for causality and is discussed elsewhere.11, 12 The high prevalence of cardiac arrhythmias after an episode of pneumonia and the temporality of this association also suggest a causal role for
Effects of pneumonia on the cardiovascular system
The present understanding of the human cardiovascular response to infections, including pneumonia, is derived mainly from studies of critically ill patients with septic shock. This disorder is characterised by inability of the peripheral vasculature to constrict despite increased concentrations of catecholamines and increased activity of the renin–angiotensin–aldosterone system;28 myocardial systolic and diastolic dysfunction, mainly of the left ventricle, with some myocardial injury manifested
New or worsening heart failure
Several mechanisms can contribute to myocardial dysfunction in patients with pneumonia. Circulating inflammatory mediators (ie, cytokines and/or endotoxins) or direct infection of cardiomyocytes with pneumonia-causing organisms, or both these mechanisms, can lead to non-ischaemic myocardial injury. Acute myocardial ischaemia
Aspirin
In a large retrospective cohort study (n=1007) of unselected patients with pneumonia admitted to hospital, investigators reported a non-statistically significant 37% reduction in short-term mortality in those patients using aspirin,82 whereas in a smaller (n=127) study of elderly patients with severe community-acquired pneumonia, the investigators showed a significant association between use of antiplatelet drugs (84% low-dose aspirin) and reduced need for intensive care and shorter hospital
Cardiovascular effects of common antibiotics
Intravenous formulations of some beta-lactam antibiotics contain substantial amounts of sodium and need frequent dosing, which might be a relevant consideration in patients with pre-existing heart failure. Typical regimens of aqueous benzylpenicillin (5 million units intravenously every 6 h) or piperacillin–tazobactam (3·375 g intravenously every 6 h), for example, can provide daily sodium loads equivalent to 1·3 g and 0·8 g, respectively; however, when sodium from the normal saline used for
Implications for clinical practice
Clinicians and public health officials should optimise rates of influenzal and pneumococcal vaccination, especially in elderly patients and individuals with chronic cardiac disorders. Because more than 50% of cardiac complications are recognised at or within 24 h of presentation with acute pneumonia, a thorough investigation for the presence of cardiac complications should be part of the initial assessment of patients presenting with this infection. Clinicians should specifically investigate
Areas for future research
The panel lists some suggested goals for future research. Previous investigations have focused mainly on characterisation of pneumonia-associated temporal changes in distinct elements of the cardiovascular system (ie, left ventricular function, peripheral vascular resistance, neuroendocrine system, and water and sodium balance) without consideration of potential interactions between them or their role in triggering cardiac complications in patients with this infection; therefore, more
Conclusions
Pneumonia is usually considered to be an acute process confined to the lungs, unless the disease is complicated by severe sepsis. However, pneumonia affects essential parts of the cardiovascular system, which is probably responsible for the substantial burden of acute cardiac complications that has been documented thoroughly in large cohorts. In view of the high incidence of cardiac complications in patients with pneumonia and the effect on mortality, the possibility of improving the outcomes
Search strategy and selection criteria
References (100)
- et al.
Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data
Lancet
(2006) - et al.
Role of acute infection in triggering acute coronary syndromes
Lancet Infect Dis
(2010) - et al.
Decreased immune responses to influenza vaccination in patients with heart failure
J Card Fail
(2009) - et al.
Risk factors for pneumonia in the elderly
Am J Med
(1994) - et al.
Association between acute infections and risk of acute coronary syndrome: a meta-analysis
Int J Cardiol
(2011) - et al.
Triggers of nonfatal myocardial infarction in Costa Rica: heavy physical exertion, sexual activity, and infection
Ann Epidemiol
(2007) - et al.
Early cardiac arrest in patients hospitalized with pneumonia: a report from the American Heart Association's Get With the Guidelines—Resuscitation Program
Chest
(2012) - et al.
Incidence, etiology, timing, and risk factors for clinical failure in hospitalized patients with community-acquired pneumonia
Chest
(2008) - et al.
Sepsis and the heart
Br J Anaesth
(2010) - et al.
Troponin-I as a prognosticator of mortality in severe sepsis patients
J Crit Care
(2010)